Please note that to receive credit you must achieve a score of at least 70%.

Physicians: Certificate of Credit will be emailed within 4 weeks of successful completion of the activity.

Pharmacists: The information that you participated will be uploaded to CPE Monitor within 4 weeks of successful completion of the activity and you will be able to access your credits from the profile you set up with NABP. For more information, please visit http://www.nabp.net/.

Question Title

1. Risk factors for the development of C. difficile infection (CDI) include all of the following except: (Required.)

Question Title

2. The least sensitive method to diagnose CDI is: (Required.)

Question Title

3. The recommended antimicrobial treatment for severe CDI (i.e., WBC ≥15,000 cells/mcL) is: (Required.)

Question Title

4. The recurrence rate after a first episode of CDI is approximately: (Required.)

Question Title

5. The most common site of bacterial infection in cancer patients is: (Required.)

Question Title

6. The most common etiology of Gram-positive bacterial infections in cancer patients is: (Required.)

Question Title

7. Which of the following antimicrobials exhibits activity primarily against Gram-negative bacteria? (Required.)

Question Title

8. Approximately what percent of patients with hematologic malignancies develop bacteremia during febrile neutropenic episodes? (Required.)

Question Title

9. Recommended initial treatment of infection caused by ESBL-producing bacteria is a(n): (Required.)

Question Title

10. Empiric antimicrobial therapy for a high-risk hematologic patient with fever and neutropenia should include a(n): (Required.)

( Privacy & Cookie Notice

T